J. John Trizzino's most recent trade in Novavax, Inc. was a trade of 28,890 Restricted Stock Units done . Disclosure was reported to the exchange on March 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax, Inc. | John J. Trizzino | President and COO | 07 Mar 2025 | 28,890 | 28,890 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | President and COO | 07 Mar 2025 | 28,890 | 82,015 (0%) | 0% | 0 | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | President and COO | 07 Mar 2025 | 13,954 | 68,061 (0%) | 0% | 8.3 | 116,376 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | President and COO | 01 Mar 2025 | 48,000 | 76,310 (0%) | 0% | 0 | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | President and COO | 01 Mar 2025 | 48,000 | 96,000 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | President and COO | 01 Mar 2025 | 23,185 | 53,125 (0%) | 0% | 8.3 | 193,131 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2024 | 655 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2024 | 655 | 28,627 (0%) | 0% | 0 | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2024 | 317 | 28,310 (0%) | 0% | 13.9 | 4,406 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | President and COO | 10 Mar 2024 | 4,608 | 4,608 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | President and COO | 10 Mar 2024 | 4,608 | 30,198 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | President and COO | 10 Mar 2024 | 2,226 | 27,972 (0%) | 0% | 5.5 | 12,132 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 07 Mar 2024 | 28,890 | 39,545 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 07 Mar 2024 | 28,890 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 07 Mar 2024 | 13,955 | 25,590 (0%) | 0% | 5.6 | 78,288 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 01 Mar 2024 | 144,000 | 144,000 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | J. John Trizzino | EVP, CCO and CBO | 14 Dec 2023 | 1,600 | 11,428 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | Trizzino John J. | EVP, CCO and CBO | 14 Dec 2023 | 1,600 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | J. Trizzino John | EVP, CCO and CBO | 14 Dec 2023 | 773 | 10,655 (0%) | 0% | 5.7 | 4,398 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2023 | 655 | 10,145 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2023 | 655 | 655 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2023 | 317 | 9,828 (0%) | 0% | 7.1 | 2,263 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 25 Jun 2023 | 833 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 25 Jun 2023 | 833 | 9,893 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 25 Jun 2023 | 403 | 9,490 (0%) | 0% | 6.7 | 2,700 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 10 Mar 2023 | 4,609 | 9,216 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 10 Mar 2023 | 4,609 | 11,531 (0%) | 0% | 6.5 | 30,051 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 10 Mar 2023 | 2,471 | 9,060 (0%) | 0% | 6.5 | 16,111 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 07 Mar 2023 | 100,100 | 100,100 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 07 Mar 2023 | 86,670 | 86,670 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 26 Sep 2022 | 3,538 | 7,804 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 26 Sep 2022 | 3,538 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 26 Sep 2022 | 1,709 | 6,095 (0%) | 0% | 18.9 | 32,249 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2022 | 655 | 1,310 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2022 | 655 | 4,583 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 19 Aug 2022 | 317 | 4,266 (0%) | 0% | 36.2 | 11,482 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 25 Jun 2022 | 833 | 833 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 25 Jun 2022 | 833 | 4,206 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 25 Jun 2022 | 278 | 3,928 (0%) | 0% | 51.7 | 14,364 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 10 Mar 2022 | 20,737 | 20,737 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 10 Mar 2022 | 13,825 | 13,825 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 14 Dec 2021 | 1,600 | 4,146 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 14 Dec 2021 | 1,600 | 3,200 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 14 Dec 2021 | 773 | 3,373 (0%) | 0% | 168.4 | 130,196 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 7,501 | 10,047 (0%) | 0% | 19.1 | 143,119 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 7,501 | 95,000 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 1,452 | 6,615 (0%) | 0% | 205.3 | 298,029 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 1,141 | 8,067 (0%) | 0% | 204.1 | 232,904 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 990 | 5,625 (0%) | 0% | 206.3 | 204,240 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 839 | 9,208 (0%) | 0% | 203.3 | 170,537 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 421 | 3,477 (0%) | 0% | 219.3 | 92,310 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 382 | 5,243 (0%) | 0% | 207.3 | 79,196 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 323 | 2,702 (0%) | 0% | 228.3 | 73,725 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 318 | 4,371 (0%) | 0% | 214.6 | 68,258 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 312 | 4,931 (0%) | 0% | 208.5 | 65,038 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 255 | 3,173 (0%) | 0% | 222.9 | 56,830 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 247 | 4,124 (0%) | 0% | 216.2 | 53,404 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 226 | 3,898 (0%) | 0% | 218.1 | 49,297 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 156 | 2,546 (0%) | 0% | 230 | 35,880 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 148 | 3,025 (0%) | 0% | 224.2 | 33,187 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 112 | 4,819 (0%) | 0% | 209.6 | 23,472 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 100 | 4,719 (0%) | 0% | 211.5 | 21,145 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 49 | 3,428 (0%) | 0% | 220.2 | 10,791 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 28 Sep 2021 | 30 | 4,689 (0%) | 0% | 213.1 | 6,393 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 7,501 | 10,047 (0%) | 0% | 19.1 | 143,119 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 7,501 | 102,501 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 1,365 | 7,740 (0%) | 0% | 231.2 | 315,530 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 1,270 | 5,546 (0%) | 0% | 233.2 | 296,225 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 924 | 6,816 (0%) | 0% | 232.0 | 214,322 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 849 | 4,697 (0%) | 0% | 234.4 | 198,984 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 628 | 9,105 (0%) | 0% | 230.2 | 144,558 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 569 | 3,392 (0%) | 0% | 239.7 | 136,397 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 369 | 4,328 (0%) | 0% | 235.8 | 86,999 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 314 | 9,733 (0%) | 0% | 228.7 | 71,807 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 297 | 2,616 (0%) | 0% | 248.2 | 73,703 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 267 | 4,061 (0%) | 0% | 236.7 | 63,211 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 212 | 3,013 (0%) | 0% | 245.0 | 51,938 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 114 | 3,278 (0%) | 0% | 240.6 | 27,428 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 100 | 2,913 (0%) | 0% | 246.5 | 24,649 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 100 | 3,961 (0%) | 0% | 237.6 | 23,758 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 70 | 2,546 (0%) | 0% | 249.0 | 17,433 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 27 Sep 2021 | 53 | 3,225 (0%) | 0% | 243.2 | 12,890 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 26 Sep 2021 | 3,537 | 3,538 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 26 Sep 2021 | 3,537 | 4,255 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 26 Sep 2021 | 1,709 | 2,546 (0%) | 0% | 248.2 | 424,105 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 7,500 | 110,002 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 7,500 | 117,502 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 7,500 | 8,218 (0%) | 0% | 19.1 | 143,100 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 7,500 | 8,218 (0%) | 0% | 19.1 | 143,100 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 1,515 | 1,086 (0%) | 0% | 230.3 | 348,923 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 1,365 | 4,765 (0%) | 0% | 226.2 | 308,821 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 1,307 | 2,759 (0%) | 0% | 228.7 | 298,935 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 1,269 | 6,130 (0%) | 0% | 224.8 | 285,262 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 1,175 | 4,644 (0%) | 0% | 226.6 | 266,311 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 1,032 | 5,819 (0%) | 0% | 225.7 | 232,905 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 918 | 1,841 (0%) | 0% | 229.9 | 211,063 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 853 | 3,327 (0%) | 0% | 228.2 | 194,674 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 819 | 7,399 (0%) | 0% | 223.9 | 183,413 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 755 | 1,086 (0%) | 0% | 230.7 | 174,167 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 726 | 2,601 (0%) | 0% | 229.0 | 166,278 | Common Stock | |
| Novavax, Inc. | John J. Trizzino | EVP, CCO and CBO | 20 Sep 2021 | 705 | 6,851 (0%) | 0% | 224.8 | 158,460 | Common Stock |